Clinical trial
Effect of Namenda on Short Term Memory and Attention in Patients With Mild to…
NCT00462228 · University of Missouri-Columbia, Other · Terminated
Key facts
| NCT number | NCT00462228 |
|---|---|
| Title | Effect of Namenda on Short Term Memory and Attention in Patients With Mild to Moderate Traumatic Brain Injury |
| Official title | Double-blind Cross-over Study of the Effect of Namenda on Short Term Memory and Attention in Patients With Mild to Moderate Traumatic Brain Injury, Protocol NAM-MD-44 |
| Lead sponsor | University of Missouri-Columbia, Other |
| Collaborators | Forest Laboratories Industry |
| Status | Terminated |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Traumatic Brain Injury |
| Intervention type | Drug |
| Interventions | Memantine, Placebo |
| Enrollment | 11 |
| Start date | Apr 1, 2007 |
| Primary completion | Dec 1, 2010 |
| Completion | Dec 1, 2010 |
| First posted | Apr 18, 2007 |
| Last update posted | Jan 23, 2017 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: